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ABSTRACT. The aim of this study was to investigate the effects of a commercial European Porcine Reproductive and Respiratory 
Syndrome (PRRS) - inactivated vaccine on health status, semen characteristics and semen fertilizing capacity in vivo of boars. In 
a farrow to finish farm that suffered from chronic course of PRRS, 7 donor boars (1.1-2.2 years old) were initially twice vaccinated, 
with a 4 weeks interval. At the same time, all gilts / sows of the herd were, also, vaccinated. Boars were monitored for abnormal 
clinical signs 24 h prior to 15 days after each vaccination. Ejaculates were collected 24 h prior, 24 h after and 15 days after each 
vaccination and the semen characteristics were evaluated. A total of 305 sows were inseminated twice with the collected semen 2 
weeks prior up to 6 weeks after the 1st vaccination. No systemic clinical signs and significant differences in semen characteristics, 
except of sperm viability, were noticed. After the 1st vaccination, sperm viability increased, but this was probably due to the increase 
of the age of 7 boars during the trial and not due to the vaccination. All semen characteristics were decreased 24h after each 
vaccination, but they were not lower than the value of accepted criteria semen quality. No change was noticed in sow's fertility 
parameters, apart from the farrowing rate, that was not, however, of clinical importance. In conclusion, the use of a PRRSV -
inactivated vaccine in boars is safe and has not negative effects on health status and their semen characteristics neither on fertilizing 
capacity in vivo. 
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ΠΕΡΙΛΗΨΗ. Σκοπός της παρούσας πειραματικής έρευνας ήταν η διερεύνηση, υπό συνθήκες εκτροφής, της in vivo επίδρασης 
του εμβολιασμού των κάπρων με το νεκρό εμβόλιο κατά του Αναπαραγωγικού και Αναπνευστικού Συνδρόμου του Χοίρου 
(ΑΑΣΧ) στην υγεία, στα ποσοτικά και ποιοτικά χαρακτηριστικά του σπέρματος των κάπρων, καθώς και στη γονιμοποιητική 
τους ικανότητα. Ο πειραματισμός πραγματοποιήθηκε σε μία «κάθετη» χοιροτροφική εκμετάλλευση, δυναμικότητας 900 συών, 
στην οποία εκδηλωνόταν η χρόνια και η ενδημική μορφή του ΑΑΣΧ. Η εκτροφή διέθετε εργαστήριο επεξεργασίας και 
συντήρησης σπέρματος. Αρχικά, οι επτά σπερματοδότες κάπροι της εκτροφής (ηλικίας 1 - 2 ετών) εμβολιάστηκαν με νεκρό 
εμβόλιο δύο φορές σε διάστημα 4 εβδομάδων. Οι εμβολιασμοί έναντι των υπολοίπων νοσημάτων απείχαν τουλάχιστον 3 
εβδομάδες από το συγκεκριμένο εμβολιακό σχήμα. Στη συνέχεια, ακολούθησαν επαναληπτικοί εμβολιασμοί, ανά εξάμηνο. 
Επίσης, όλες οι σύες της εκτροφής εμβολιάστηκαν με το ίδιο εμβόλιο και για το ίδιο χρονικό διάστημα. Στους εμβολιασμένους 
κάπρους πραγματοποιούνταν καθημερινά κλινική εξέταση έως και 15 ημέρες μετά από κάθε εμβολιασμό. Τα εκσπερματίσματα 
που συλλέχθηκαν 24 ώρες πριν, καθώς και 24 ώρες και 15 ημέρες μετά, αντίστοιχα, από κάθε εμβολιασμό, αξιολογήθηκαν με 
βάση τον προσδιορισμό του όγκου, της ζωτικότητας και της πυκνότητας του σπέρματος. Η εκτίμηση της γονιμοποιητικής 
ικανότητας του σπέρματος έγινε με βάση την in vivo χρησιμοποίηση των δόσεων του σπέρματος, που προέκυψαν 2 εβδομάδες 
πριν έως και 6 εβδομάδες μετά από τον πρώτο εμβολιασμό των κάπρων. Με τον τρόπο αυτό, εφαρμόστηκε τεχνητή σπερματέγχυση 
συνολικά σε 305 σύες. Η σπερματοληψία, η εκτίμηση των χαρακτηριστικών του σπέρματος, ο καθορισμός του αριθμού των 
δόσεων, η επεξεργασία και η συντήρηση του σπέρματος έγινε σύμφωνα με το πρωτόκολλο που εφάρμοζε η εκτροφή. Κατά τη 
διάρκεια του πειραματισμού, δεν παρατηρήθηκαν κλινικά συμπτώματα, τοπικές αντιδράσεις στο σημείο της έγχυσης του 
εμβολίου ή άλλες παρενέργειες στους εμβολιασμένους κάπρους. Από την ανάλυση των αποτελεσμάτων προέκυψε ότι ο εμβο­
λιασμός των κάπρων δεν επηρέασε τον όγκο, την κινητικότητα και την πυκνότητα του σπέρματος. Αντίθετα, επηρεάστηκε η 
ζωτικότητα του σπέρματος, οι τιμές της οποίας αυξήθηκαν στους επαναληπτικούς εμβολιασμούς, πιθανότατα λόγω της 
προοδευτικής αύξησης της ηλικίας των κάπρων παρά λόγω του εμβολιασμού. Επίσης, αν και παρατηρήθηκε μείωση στα χαρα­
κτηριστικά του σπέρματος 24 ώρες μετά από κάθε εμβολιασμό, οι τιμές τους κυμάνθηκαν σε φυσιολογικά επίπεδα. Τέλος, 
όσον αφορά την in vivo επίδραση του εμβολιασμού των κάπρων στη γονιμοποιητική ικανότητα του σπέρματος τους, διαπιστώθηκε 
ότι δεν επηρεάστηκε αρνητικά κατά τη διάρκεια ενός πλήρους σπερματογονικού κύκλου. Το μέγεθος της τοκετοομάδας δεν 
παρουσίασε σημαντικές διαφορές μεταξύ των διαφόρων πειραματικών ομάδων των συών, ενώ το ποσοστό τοκετών αυξήθηκε 
σημαντικά σην ομάδα των συών που γονιμοποιήθηκαν με σπέρμα που συλλέχθηκε 1-2 εβδομάδες μετά τον πρώτο εμβολιασμό 
των κάπρων και μειώθηκε στην ομάδα των συών που γονιμοποιήθηκαν με σπέρμα που συλλέχθηκε 5-6 εβδομάδες μετά τον 
πρώτο εμβολιασμό. Συμπερασματικά, ο εμβολιασμός των κάπρων παρέχει απόλυτη ασφάλεια, αφού δεν προκαλεί παρενέργειες 
και δεν επηρεάζει αρνητικά τα χαρακτηριστικά και τη γονιμοποιητική ικανότητα του σπέρματος. 
Λέξεις ευρετηρίασης: Αναπαραγωγικό και Αναπνευστικό Σύνδρομο του χοίρου, εμβόλιο, σπέρμα, γονιμοποιητική ικανότητα, 
κάπρος 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) has caused tremendous economic losses 
in the global swine industry since the early 1990's. The 
etiologic agent is an enveloped, RNA virus, named 
PRRSV (Meulenberg et al. 1997), which is a member 
of the Arteriviridae family (Cavanagh 1997). 
Clinical signs of PRRS include anorexia, lethargy, 
and respiratory signs, moderate pyrexia, recumbency 
and in addition may lack libido (Yaeger et al. 1993; 
Prieto et al. 1996b). A significant decrease of sperm 
motility and morphological abnormalities (e.g. 
decrease of number of spermatozoa with intact acro-
some) were noticed 2-10 weeks after PRRSV infection 
sperm motility (Yaeger et al. 1993, Prieto et al. 1996b, 
Christopher-Henninigs et al. 1997). Although PRRSV 
can be transmitted through the semen and can be a 
significant portal entry into susceptible herds (Yaeger 
et al. 1993, Swenson et al. 1994), it is not clear up today 
the impact of PRRS viremia on boars at the time of 
conception (Yaeger et al. 1993, Lager et al. 1996, 
Prieto et al. 1996a,c). 
In the literature, there is little in formations on 
PRRS V vaccination of boars. Most of the studies are 
reffered to the use of them, used modified live vaccines 
(MLV), showing that the use of MLV in boars is under 
discussion, because it causes clinical signs (anorexia, 
lethargy, recumbency, fever) and has negative effects 
on semen characteristics, such as reduction of semen 
volume and sperm viability (Vilaca et al. 2001). 
Additionally, it has been shown that MLV virus can 
persist in boars and can be transmitted through semen 
(Christopher-Hennings et al. 1997). 
At the present, only two studies have been 
published regarding the use of inactivated vaccines in 
boars, one with vaccine of American strain (Swenson 
et al. 1995) and one with the European strain (Nielsen 
et al. 1997) of PRRS. Swenson et al. (1995) indicated 
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that the vaccination of boars with inactivated vaccine 
does not cause clinical signs and may reduce or prevent 
seminal shedding. On the contrary, Nielsen et al. 
(1997) using inactivated vaccine, observed a moderate 
to considerable swelling at the injection-site and no 
changes in viremia and shedding of virus in semen. 
However, none of them investigated the effects of 
inactivated vaccine on semen characteristics and 
semen fertilizing capacity in vivo. 
In the present field study, the aim was to investigate 
the effects of vaccination with a commercial European 
PRRSV-inactivated vaccine after 18 month-use of 
donor boars on health status, semen characteristics and 
semen fertilizing capacity in vivo. It should be noted 
that this study is the first report regarding the testing of 
the commercial inactivated "PROGRESSES®" vaccine 
in boars. 
Materials and Methods 
Experimental material 
The commercial inactivated "PROGRESSIS®" 
vaccine (Merial, SAS), based on the European P120 
strain, was used. The vaccine dose contains >10 2 5 IF 
units and is suspended in 2 ml of an oily adjuvant 
(hydrogenated polyisorbutene is the oily part of the 
emulsion of mineral oil in water) for intramuscular 
injection behind the ear. 
Trial farm 
The trial has been performed in a commercial all-
in, all-out farrow-to-finish farm with a capacity of 900 
sows located in Katerini, Macedonia, Greece. A 
grandparent nucleus of 70 sows was kept in the farm 
for producing own gilts and these animals were 
separately housed, but in the same premises such as a 
commercial herd. The farm facilities included 4 
farrowing houses, 5 flat-deck units, 6 growing houses, 
6 finishing houses, 4 mating-pregnancy (dry period) 
stables, 1 breeding stock house, a feed mill and an 
artificial insemination (AI) laboratory. Records in the 
farm were kept electronically. 
Seven healthy crossbred adult boars (1-2 years old) 
of the same genetic background were included in this 
study. All boars were housed in individual pens of the 
mating-pregnancy building under the same environ­
mental, feeding and management conditions. Semen 
collection was performed one to two times per week 
according to the routine programme of the trial farm. 
An Artificial Insemination (AI) programme with 
raw semen was applied by the trial farm and sows were 
inseminated twice with fresh semen from the same 
boar. Semen collection, dilution and storage were per­
formed in the farm (system "Do-it-yourself AI"). The 
collected semen was diluted with a commercial BTS 
(Beltsville Thaw Solution, Androhep® by Minitube 
International) extender to a concentration of approxi­
mately 30 million sperm/ml. Each gilt/sow was insemi­
nated twice 12 and 24 h after the detection of oestrus 
by a teaser boar. 
All gilts / sows of the farm were vaccinated against 
Aujeszky's disease (AD), swine influenza (SI), parvo­
virus infection, atrophic rhinitis (AR), erysipelas, 
Escherichia coli and Clostridium perfringens infections 
{type A and C). All boars were vaccinated every 6 
months against erysipelas, AD and SI, fattening pigs 
against AD and SI and weaners against Mycoplasma 
hyopneumoniae. For the antiparasitic control, all 
breeding females were treated with a single ivermectin 
injection 14 days prior to each farrowing, while the 
boars treated similarly twice a year. The feed provided 
to the animals was self-prepared, mainly consisted of 
based corn/barley/wheat-soya meal, depending on the 
season. 
Farm history 
The farm had suffered an acute PRRSV infection 
5 years prior to the initiation of the trial. Since then, 
the herd had been infected with PRRSV for some 
years and had never been vaccinated before against 
PRRSV. For at least one-year prior the initiation of 
the trial, the farm was diagnosed PRRS-positive, based 
on clinical signs (low reproductive performance as was 
evidenced by increased returns to oestrus, small litters, 
weak piglets and increased piglet mortality), serology 
examination of blood samples and detection of viral 
RNA by PCR from fetuses and newborn piglets. In 
addition, blood samples of sows were examined for 
antibodies against a European PRRSV by using 
indirect immunofluorescence assay in US- or EU-type 
PRRSV-infected MA104 cells. It was shown that the 
circulating strain in the farm was a European strain. 
The management, vaccination status, nutrient 
specification and feeding schedule of the farm 
remained the same during the pre-trial and trial period. 
Experimental design 
Primary vaccination of all boars was performed by 
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administering (intramuscularly behind the ear) 2 doses 
of PROGRESSES®, 3-4 weeks apart. This 1st vaccina­
tion was separated by at least 3 weeks from other 
boars' vaccinations and all boars were boostered twice 
per year, for a period of 18 months. 
All gilts / sows of the herd were primarily subjected 
to the first vaccination as previously described, except 
those being 1 week prior - to 2 weeks post - service. The 
skipped females were subjected to primary vaccination, 
starting, however, 3 weeks later. All previously vacci­
nated animals received a booster vaccination between 
55 and 60 days of next gestation and, thereafter, at each 
gestation for a period of 18 months. The gilts were 
vaccinated twice prior to breeding (1st vaccination) and 
boostered in each pregnancy as previously described. 
All procedures during this clinical study were 
carried out according to the Code of Practice for the 
Conduct of Clinical trials for Veterinary Medical 
Products and the animals were maintained in accor­
dance with National and European animal Welfare 
requirements (OECD 1998, European Agency for the 
Evaluation of Medicinal Products 1999, FVE 2001). In 
addition, the present study was performed under 
license for experimenting on animals from the local 
Veterinary Administration Office (Katerini district 
Veterinary State Authority, License No 07/1855). 
Records 
Clinical observations 
Boars were monitored for abnormal clinical signs 
24 h prior to 15 days after each vaccination. The rectal 
temperature and bodyweight of the 7 boars were, also, 
monitored 24 h after each vaccination. 
Evaluation of semen characteristics 
Ejaculates were collected 24 h prior, 24 h after and 
15 days after each vaccination. Semen evaluation was 
based on microscopic (sperm concentration, viability 
and motility) and macroscopic (semen volume) 
characteristics. 
Semen collection, evaluation, dilution, estimation 
of insemination doses and storage of doses were 
performed in accordance with the protocol of the trial 
farm. Semen volume was determined by directly 
reading of the scale marked in ml from the vial of 
semen collection. Sperm density was determined by 
using the photometer (Accucell, Product code: 014434, 
Imv-Technologies) of the laboratory in the trial farm. 
Sperm viability and motility were estimated imme­
diately after semen collection. Samples of raw semen 
1:10 with a commercial BTS (Beltsville Thaw Solution, 
Androhep® by Minitube International) extender to a 
concentration of approximately 30 million sperm / ml, 
microscopic examination (lOOx) followed after 
diluting. Microscopic examination of semen slides 
stained with eosin-nigrosin was performed, in order to 
confirm the percentage of live spermatozoa. Sperm 
motility was evaluated by a microscope (Carl Zeiss, KF 
2 ICS), equipped with a heated-plate (37 ° C). A semen 
sample (10μ1) was applied in a pre-warmed slide and 
covered by a cover ship. At least ten different slides of 
each sample were examined by the same person. 
Evaluation of semen fertilizing capacity in vivo 
A total of 305 sows with semen doses from 
ejaculates that were collected 2 weeks prior up to 6 
weeks after the 1st vaccination were inseminated. 
Farrowing data, including litter size (total born and live 
born piglets), were recorded for all the above animals. 
Data analysis 
The results were analyzed with the Statistical 
Analysis System (SAS) programme, which is installed 
in the central computer system of the Clinic of Pro­
ductive Animals Medicine with the code 0084912001 
(SAS 2002). The one-way Anova test for quantitative 
parameters was used; the Tukey's test was, also, used, 
in order to detect significant differences between the 
groups. The homogeneity of variance was checked 
using the test of Levene. In cases when the trans­
formations of real prices did not bring about the 
expedient homogeneity of fluctuations, the test of 
Kruskall-Wallis was used. The Fisher's test was used 
for the qualitative parameters. In all cases, significance 
was taken at the level of importance P<0.05. 
Results 
Sides effects-Clinical observations 
No systemic clinical signs and no local reaction on 
the area of the injection in all boars after the daily 
examination, 24 h prior to 15 days after each injection 
of all vaccinations were observed. Moreover, all boars 
performed normal appetite, behaviour and normal 
libido after each vaccination. 
The average rectal temperature of each boar 24 h 
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after 4 vaccinations is shown in Table 1 and Table 2, 
respectively. The average rectal temperature was 
always higher than normal mean (38.6 °C) in all boars. 
No significant statistical difference between the 7 boars 
regarding the average rectal temperature was observed 
during the period of vaccination. 
Semen characteristics 
The mean values for semen characteristics (semen 
volume, sperm concentration, viability and motility) 
that resulted from the examination (microscopic and 
Table 1. Average rectal temperature 24 hours after 
4 vaccinations (mean ± SD, n= number of observations) 
Boar 
1 
2 
3 
4 
5 
6 
7 
Total (n=7 boars) 
Rectal temperature (°C) 
(n=4 vaccinations) 
39.1 ± 0.30 a 
39.2 ± 0.31 a 
39.5 ± 0.55 a 
39.3 ± 0.62a 
39.1 ± 0.24 a 
39.3 ± 0.17 a 
39.3 ± 0.31 a 
39.3 ± 0.37 a 
a
 Means in column with same superscripts do not differ significantly 
(P>0.05). 
macroscopic) of the ejaculates collected at 24 h prior, 
24 h after and 15 days after each vaccination, are 
shown in Tables 3 and 4. 
No significant differences in semen volume and 
sperm motility prior and after the 1st vaccination were 
noticed. However, a significant decrease (P<0,05) in 
sperm viability 24 h and 15 days after the 1st vaccination 
compared to the corresponding viability at 24 h prior 
the primary vaccination was observed. In addition, a 
significant reduction (P<0,05) in sperm concentration 
of ejaculates collected 15 days after the primary 
vaccination compared to sperm concentration 24 h 
prior the primary vaccination was, also, observed. 
Finally, it should be noted that, during this 
investigation, all boars were not used with the same 
frequency for the evaluation of the in vivo fertilizing 
capacity of sperm. Three out of seven boars were used 
with a lower frequency of semen collection than the 
expected frequency of 1-2 collections per week. More 
specifically, one boar was not used from the 2nd up to 
the 14th day and two other boars were not used from 
the 2nd up to the 7th and from the 7th up to the 14th day 
after the primary vaccination, respectively. 
Table 2. Average rectal temperature 24 hours before the 1st and 24 h after each vaccination (mean ± SD) 
Boar 
1 
2 
3 
4 
5 
6 
7 
Total (n=7 boars) 
24 h before 
1st vaccination 
38.4 ± 0.16a 
38.4 ± 0.28a 
38.6±0.10 a 
38.5 ± 0.24a 
38.4 ± 0.30a 
38.5 ± 0.15a 
38.5 ± 0.20a 
38.6 ± 0.24 
Rectal temperature 
24 h after 
1st vaccination 
39.1 ± 0 . 3 0 a 
39.2 ± 0.31a 
39.5 ± 0.55a 
39.3 ± 0.62a 
39.1 ± 0 . 2 4 a 
39.3 ± 0 . 1 7 a 
39.3 ± 0.31a 
39.3 ± 0.37 
24 h after 
2nd vaccination 
39.3±0.10 a 
39.1 ± 0 . 2 5 a 
39.2±0.10 a 
39.1 ± 0 . 3 6 a 
39.2 ± 0.30a 
39.2 ± 0.40a 
39.5±0.10 a 
39.2 ± 0.23 
(rc) 
24 h after 
3rd vaccination 
39.1 ± 0 . 2 5 a 
39.4 ± 0.35a 
39.1 ± 0 . 1 5 a 
39.4 ± 0.27a 
39.3 ± 0 . 1 7 a 
39.5 ± 0.47a 
39.2 ± 0.24a 
39.1 ± 0.37 
24 hafter 
4th vaccination 
39.2 ± 0.23a 
39.2 ± 0.34a 
39.3 ± 0.45a 
39.2±0.32 a 
39.2 ± 0.22a 
39.1 ± 0 . 3 6 a 
39.4±0.14 a 
39.3 ± 0.37 
a
 Means in column and row with same superscripts do not differ significantly (P>0.05). 
Table 3. Semen characteristics (mean ± SD) after each vaccination 
Parameter 
Vaccinat ion 
Semen volume (ml) 
Sperm concentration (X 106/ml) 
Sperm viability (%) 
Sperm motility (%) 
218.09 ± 46.56a 
352.86 ± 57.44a 
75.71 ± 6.22b 
75.48 ± 6.85a 
242.86 ± 48.68a 
324.29 ± 68.68a 
80.37 ± 3.47a 
74.76 ± 4.85a 
251.19 ± 48.92a 
314.29 ± 74.53a 
81.67 ± 4.30a 
74.29 ± 4.80a 
244.05 ± 52.63a 
296.19 ± 43.64a 
81.19 ± 3.81a 
75.95 ± 6.86a 
' Means in a row with different superscripts differ (P<0.05). 
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Table 4. Semen characteristics (mean± SD) at each time of semen evaluation for the total trial period 
Vaccination Time of 
vaccination 
Semen volume 
(ml) 
Sperm concentration 
(xlOVml) 
Sperm viability 
(%) 
Sperm motility 
(%) 
1st 
24 h prior 
24 h after 
15 days after 
235.71 : 
227.86 : 
190.71 
t 69.00a 
t 55.67a 
± 3 6 . 8 a 
334.29 
325.71 
398.57 
84.69a 
68.28a 
64.66a 
80.00 ± 5.77a 
72.86 ± 8.09b 
74.29 ± 7.32b 
78.57 : 
72.86 : 
74.29 : 
6.27a 
9.51a 
9.13a 
24 h prior 
24 h after 
15 days after 
260.42 : 
221.43 : 
242.86 : 
: 59.26a 
: 46.61b 
53.45 a'b 
342.86 
300.00 : 
330.00 : 
: 64.99a 
: 58.88b 
90.37 a'b 
85.00 ± 4.08a 
77.14 ± 4.88b 
82.86 ± 2.67 a'b 
76.43 : 
71.43 : 
76.84 : 
5.56a 
5.18a 
4.92a 
24 h prior 
24 h after 
15 days after 
253.57 : 
225.00 : 
275.00 : 
: 60.26a 
47.87b 
: 45.64a 
324.29 
295.71 
322.86 
68.03a 
77.86a 
81.18a 
82.86 ± 4.88a 
77.86 ± 4.32b 
84.29 ± 3.45a 
77.02 : 
70.71 : 
75.71 : 
: 4.32a 
4.50b 
:5.34a 
24 h prior 
24 h after 
15 days after 
254.14 : 
214.29 : 
264.29 : 
: 59.36a 
53.73 b 
: 49.70a 
320.00 
262.86 : 
305.71 
: 62.98a 
35.46b 
: 42.76a 
84.57 ± 4.45a 
76.92 ± 4.12b 
82.14 ± 3.93a 
77.97 : 
71.12 : 
77.86 : 
:5.01a 
8.52b 
:6.99a 
:
 Means in a column with different superscripts differ (P<0.05). 
Table 5. Sow fertility parameters indicating semen fertilizing capacity (mean ± SD, n = number of cases) 
Time of semen collection and AI regarding vaccination 
1-2 weeks 1-2 weeks 3-4 weeks 5-6 weeks 
SOWS 
Farrowing rate (%) 
Litter size 
GROUP 1 
60/77 
(77,9%a-b-c) 
11,45 ± 3,26 a 
(n=77) 
GROUP 2 
71/83 
(85,5%a) 
11,85 ± 2,93 a 
(n=83) 
GROUP 3 
45/58 
(77,6%a-b-c) 
11,75 ± 1,64 a 
(n=58) 
GROUP 4 
63/87 
(72,4%b) 
12,05 ± 2,14 a 
(n=87) 
;
 Means in a row with different superscripts differ (P<0.05). 
Semen fertilizing capacity in vivo 
Table 5 presents the farrowing rates and mean 
litter sizes for the four experimental groups. No 
significant differences between the four experimental 
groups were observed, except of the farrowing rate in 
Group 4, which was significantly lower than in Group 
2. However, the above decrease of farrowing rate has 
no clinical importance, probably due to the season of 
AI (early summer). 
Discussion 
Safety is one of the major factors that determine 
vaccine usage. Vaccination continues to be the only 
safe, reliable and effective way to protect animals 
against the major infectious diseases. Nevertheless, the 
use of vaccines is not free of risk. Residual virulence 
and toxicity, allergic responses, disease in immuno-
deficient hosts and neurological complications asso­
ciate with the use of vaccines (Tizard 2004). The 
absence of general or due to PRRS clinical signs and 
local reactions on the area of injection in all vaccinated 
boars used for this study leads to the conclusion that 
the tested inactivated vaccine is safe. Moreover, the 
increase of the rectal temperature that was observed 
in boars at the first 24h after each injection should 
probably be considered a normal response to the 
vaccination, as it is well-known that any vaccination 
induces stress to boars (Flowers 1997). Body tempera­
ture fluctuations should not be a measure of the 
clinical status of the animal, unless accompanied by 
other clinical findings (Houston and Radostits 2001). 
Concerning the safely of the tested inactive vaccine 
against PRRS, the above findings of the present study 
are in agreement with the observations reported by 
Swenson et al. (1995). However, it contradicts with the 
results of a previous study (Nielsen et al. 1997), where 
a moderate to considerable swelling at the injection-
site was observed. In addition, Vilaca et al. (2001, 
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2003) noticed that after the use of MLV, boars 
presented anorexia, lethargy, recumbency and rectal 
temperature above 39,5 °C for 4-5 days. Thus, the 
results of the present study, in combination with those 
referred to in the literature about vaccination of boars, 
confirm that the vaccination of boars against PRRS 
with an inactivated vaccine is safer than that with an 
MLV. Moreover, in our previous study (Papatsiros et 
al. 2006), it was indicated that the use of the same 
inactivated vaccine on gilts/sows of the same experi­
mental farm was safe, since no adverse or side effects 
were observed. Furthermore, the vaccination of sows 
with "PROGRESSIS®" proved to reduce the negative 
effects of PRRSV on the breeding herd, especially as 
it concerns reproductive parameters and litter cha­
racteristics. 
In addition, in similar studies with MLV, signi­
ficant changes in the semen quality after the vacci­
nation, such as a reduction in semen volume and sperm 
motility were observed (Christopher-Hennings et al. 
1997, Vilaca et al. 2001,2003). On the contrary, in this 
study, the mentioned semen characteristics were not 
influenced in vivo fertility parameters, which were 
remained within normal ranges. The semen quality was 
not influenced, as the values remained significantly 
higher than 70%, which is considered as the acceptable 
limit of the raw semen for artificial insemination 
(Flowers 1997). Moreover, it was, also, noticed that the 
finding that sperm motility, which is considered as a 
valuable measure for the evaluation of semen quality 
(Britt et al. 1999), was not influenced and remained in 
levels higher than 70%, led to the assumption that 
semen quality remained unaffected after vaccination. 
However, it is known that the semen fertilizing capacity 
decreases (reduction of farrowing rates and litter size) 
when sperm motility is lower than 60% (Flowers 1997). 
The rapid spread and economic impact of PRRS 
have made it a frequent topic of research regarding its 
control. As with many other infectious diseases, the 
most effective means for control often depends on the 
use of vaccines. Regarding this option, there are 
currently several commercially available vaccines. 
These include MLV, as well as inactivated vaccines. 
However, the pig's immune response to PRRSV 
makes the development of an unquestionably safe and 
highly effective vaccine a formidable challenge. How­
ever, the results of the present study indicate that the 
boars' vaccination with the tested inactivated vaccine 
is safe. Furthermore, all boars can be regarded as 
normally fertile concerning the following parameters: 
semen volume, sperm concentration, motility and 
viability. 
Taking into account how significant is the pro­
duction and use of high quality semen for the global 
swine industry, the above results have an important 
financial impact (Leiding 2000). Regarding the bio-
security of swine, it seems that inactivated vaccines 
have important advantages compared to MLV, herds, 
since they do not induce shedding of the vaccine virus 
(Swenson et al. 1995), as it happens with MLV 
(Nielsen et al. 1997, Vilaca et al. 2001, 2003). Further 
studies are needed on boars vaccination with the same 
inactivated vaccine "PROGRESSIS®" and they should 
focus on the reduction of PRRSV shedding in semen. 
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